UPDATED RESULTS FROM A PHASE 1B STUDY OF AMDIZALISIB, A NOVEL INHIBITOR OF PHOSPHOINOSITIDE 3‐KINASE‐DELTA (PI3Kδ), IN PATIENTS WITH RELAPSED OR REFRACTORY LYMPHOMA

作者:J. Cao; D. Ji; Z. Li; D. Li; Q. Zhang; L. Li; M. Zhang; W. Yang; F. Li; Z. Zhu; B. Xu; Y. Chen; A. Liu; Z. Zhai; X. Zhang; Q. Wen; R. Feng; Z. Xu; H. Xue; Y. Cao; S. Gao; X. Guo; J. Yang; D. Chen; S. Fan; M. Shi; W. Su
来源:Hematological Oncology, 2023, 41: 803-804.
DOI:10.1002/hon.3165_653